DA
ITCI

Duality Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Duality Advisers’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,805
Closed -$2.08M – 745
2023
Q2 		$2.08M Buy
+32,805
New +$2.04M 0.26% 148
2023
Q1 		– Sell
-23,809
Closed -$1.26M – 805
2022
Q4 		$1.26M Sell
23,809
-30,273
-56% -$1.52M 0.14% 258
2022
Q3 		$2.52M Buy
54,082
+2,257
+4% +$118K 0.27% 140
2022
Q2 		$2.96M Buy
+51,825
New +$2.94M 0.29% 112

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return